Champions Oncology, Inc. (CSBR)

CIK 0000771856 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2026 8-K (2026-07-27) · 99.1
Latest Q3-2026 8-K (2026-03-12) · 99.1
Q2-2026 8-K (2025-12-15) · 99.1
Q1-2026 8-K (2025-09-15) · 99.1
FY-2025 8-K (2025-07-23) · 99.1
Q3-2025 8-K (2025-03-11) · 99.1
Q2-2025 8-K (2024-12-11) · 99.1
Q1-2025 8-K (2024-09-11) · 99.1
FY-2024 8-K (2024-07-18) · 99.1
Q3-2024 8-K (2024-03-12) · 99.1
Q2-2024 8-K (2023-12-12) · 99.1
Q1-2024 8-K (2023-09-13) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Unaudited Condensed Consolidated Statements of Operations
—
Consolidated Statements of Operations
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Equity
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Equity (deficiency)
—
Consolidated Statement of Changes In Stockholders (deficiency) Equity
—
Consolidated Statements of Changes In Stockholders’ Equity
—
Unaudited Condensed Consolidated Statements of Cash Flows
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Receivable, Unbilled Services and Deferred Revenue
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Earnings Per Share
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Organization and Basis of Presentation
—
Organization, Use of Estimates and Basis of Presentation
—
Pay Vs Performance Disclosure
Property and Equipment
Provision For (benefit From) Income Taxes
—
Related Party Transactions
Revenue From Contracts With Customers
Share-based Payments
—
Significant Accounting Policies
—
Significant Customers
—
Stock-based Payments
Subsequent Events
Summary of Significant Accounting Policies
—